| Quantity | Price per tablet | You save | Total price | |
|---|---|---|---|---|
| 30 | C$4.34 | - | C$130.20 | |
| 60 | C$3.55 | C$47.60 | C$212.80 | |
| 90 | C$3.28 | C$95.20 | C$295.40 | |
| 120 | C$3.15 | C$142.80 | C$378.00 | |
| 180 | C$3.01 | C$239.40 | C$541.80 | |
| 270 | C$2.93 | C$380.80 | C$791.00 | |
| 360 | C$2.89 | C$523.60 | C$1,038.80 |
Your order is securely packed and usually ships within 24 hours. Here is what a typical package looks like.
It is about the size of a regular letter (24x11x0.7 cm) and does not show any details about what is inside.
| Shipping Method | Estimated delivery |
|---|---|
| Express Free for orders over C$420.00 | Estimated delivery to Canada: 4-7 days |
| Standard Free for orders over C$280.00 | Estimated delivery to Canada: 14-21 days |
Actoplus Met is a fixed-dose treatment used with diet and physical activity to improve blood glucose control in adults with type 2 diabetes. In Canada, the brand may be less familiar than its individual components or other combination therapies. Canadians should distinguish the catalogue product from locally authorized alternatives and verify the status of the exact product and strength through Health Canada's Drug Product Database.
Many Canadians are familiar with metformin as a common starting treatment for type 2 diabetes. Pioglitazone-containing therapy is considered more selectively because factors such as heart failure risk, fluid retention, bone health, and individual treatment goals affect whether it is appropriate. A fixed-dose combination may simplify a suitable regimen, but availability through a Canadian community pharmacy and the authorization status of the exact branded product must be confirmed rather than assumed.
Consistency is important with this medicine. Take Actoplus Met at approximately the same times each day and follow the directions provided by your prescriber and pharmacist. Regular appointments and laboratory monitoring help the care team assess blood glucose control, kidney and liver function, and whether the treatment remains appropriate.
Many people find it easier to connect treatment with an established daily habit. If the prescribed regimen includes morning and evening doses, breakfast and the evening meal can provide practical reminders during a busy workday or family routine. The dosing schedule should not be changed without advice from the prescriber responsible for the diabetes treatment plan.
Actoplus Met should be taken with meals, which can reduce digestive side effects associated with metformin. This can fit naturally with familiar Canadian routines, whether breakfast is oatmeal and coffee, lunch is a sandwich, or dinner is the main family meal. Ordinary foods and moderate amounts of coffee or tea do not need to be excluded specifically because of this medicine. Heavy or prolonged alcohol use should be avoided because alcohol can increase the risk of metformin-associated lactic acidosis and make blood glucose less predictable.
Hypoglycemia is uncommon when this combination is used alone, but the risk increases when it is combined with insulin, a sulfonylurea, or certain other glucose-lowering medicines. Low blood glucose can impair concentration and reaction time, so do not drive or operate machinery if symptoms such as sweating, shaking, confusion, or dizziness occur. Pioglitazone can cause or worsen fluid retention and is unsuitable for people with heart failure. New swelling, rapid weight gain, breathlessness, or unusual fatigue requires prompt medical attention.
General Canadian diabetes discussions often describe fixed-dose combination tablets as convenient because they can reduce the number of separate medicines in a routine. Common practical challenges include digestive discomfort during the adjustment period, weight gain or swelling associated with pioglitazone, and keeping up with laboratory monitoring. Experiences shared in patient communities can help people identify questions for a pharmacist or prescriber, but they cannot predict how another person will respond.
Access can also be more complicated outside major population corridors. Rural, northern, and remote communities may have fewer nearby pharmacy options, while people in large centres may have a wider choice of community and online pharmacy services. Regardless of location, continuity with a pharmacist or prescriber remains important for a medicine that requires ongoing monitoring.
Canadians commonly use chains such as Shoppers Drug Mart, Rexall, London Drugs in Western Canada, and Pharmasave, as well as independent community pharmacies. The availability and price of the exact Actoplus Met product should be confirmed directly with the chosen pharmacy. Costs can vary according to the pharmacy, dispensing fees, insurance arrangements, and the rules of a provincial or territorial drug plan. A pharmacy name does not establish current stock, coverage, or a particular price.
Online pharmacy services can be practical for Canadians who live far from a full-service pharmacy, have limited transportation, or find it difficult to visit a pharmacy during business hours. They may also help people manage repeat medicine access across Canada's long distances. Pharmacies and online pharmacy operations are licensed through provincial or territorial regulators, and NAPRA provides information that can help consumers identify the appropriate regulator. Online access complements rather than replaces clinical follow-up and local pharmacy support.
Canada does not have one identical national outpatient drug plan. Provincial and territorial public drug plans, employer benefits, private insurance, and direct payment create different access routes. The listing or reimbursement of the exact Actoplus Met product cannot be inferred from general diabetes coverage and should be checked with the relevant plan or insurer. Canada's Drug Agency may provide health-technology assessments and recommendations, but these do not by themselves establish individual eligibility, provincial coverage, or a pharmacy price.
Actoplus Met combines metformin and pioglitazone in one tablet. Metformin, which is also available as Metformin, reduces glucose production by the liver and improves the body's response to insulin. Pioglitazone activates a receptor called PPAR-gamma, improving insulin sensitivity in fat and muscle tissue. These complementary actions can lower blood glucose from two different directions.
This combination is used as an adjunct to diet and physical activity to improve blood glucose control in adults with type 2 diabetes. It is not indicated for type 1 diabetes or diabetic ketoacidosis and should not be used in children. A clinician may consider metformin with another glucose-lowering medicine when metformin alone does not provide adequate control, but the choice depends on cardiovascular and kidney health, adverse-effect risks, treatment goals, and the person's other medicines.
Take Actoplus Met with meals. Heavy alcohol intake should be avoided because it can increase the risk of lactic acidosis associated with metformin and may disrupt blood glucose control. Insulin, sulfonylureas, and other glucose-lowering medicines can increase the risk of hypoglycemia when used with this combination. Before starting a new prescription medicine, non-prescription medicine, or supplement, ask a pharmacist or prescriber to check for interactions.
Some medicines can alter the effects or exposure of pioglitazone or metformin. Examples include gemfibrozil, rifampin, carbonic anhydrase inhibitors such as topiramate, and medicines that can reduce kidney function. This does not mean every combination must be avoided, but it may require closer monitoring or a treatment adjustment.
Current diabetes care emphasizes individualized treatment. SGLT2 inhibitors and GLP-1 receptor agonists may be prioritized for some people with cardiovascular disease, heart failure, chronic kidney disease, or particular weight-management goals. Pioglitazone remains an established glucose-lowering option for selected adults, but its potential to cause fluid retention, weight gain, and fractures must be considered. No single combination is the best choice for everyone.
Patients and prescribers may compare Actoplus Met with other single-ingredient or combination treatments according to treatment goals, tolerability, medical history, cost, and verified coverage.
| Option | Medicine or class | Practical consideration |
|---|---|---|
| Actoplus Met | Metformin and pioglitazone | Fixed-dose combination; requires attention to fluid retention and heart failure risk |
| Janumet | Metformin and sitagliptin | DPP-4 inhibitor combination with a different adverse-effect profile |
| Jentadueto | Metformin and linagliptin | DPP-4 inhibitor combination; kidney function still matters because it contains metformin |
| Jardiance | Empagliflozin, an SGLT2 inhibitor | May provide cardiovascular or kidney benefits for suitable patients; does not contain metformin |
Other possibilities include separate metformin and pioglitazone tablets or medicines from other glucose-lowering classes. Switching products or separating the ingredients can change dosing, monitoring, and cost, so alternatives should be reviewed with the prescriber and pharmacist.
The listed product identity does not confirm a current Health Canada authorization or Canadian prescription classification for the exact Actoplus Met 15 mg/500 mg tablet. Health Canada's Drug Product Database should be checked for current information about the exact product and strength. Separately, our store requirement for Actoplus Met does not include a prescription. This store policy does not establish the medicine's legal classification in Canada or replace the clinical oversight needed for diabetes treatment. Suspected adverse reactions may be reported to Health Canada through the Canada Vigilance program.
Store Actoplus Met tablets at 25°C; excursions from 15°C to 30°C are permitted. Keep the container tightly closed and protect the tablets from moisture and humidity. In a Canadian home, avoid steamy bathroom cabinets, sun-heated windowsills, and vehicles during warm weather. In winter, do not leave the medicine in an unheated porch, vehicle, mailbox, or community mail compartment, where it may freeze or fall below the permitted range. Bring a delivery indoors promptly and ask a pharmacist for advice if the tablets may have experienced unsuitable conditions.
When you order Actoplus Met from us, estimated delivery is 4 to 7 days with tracked Express shipping or 14 to 21 days with untracked Standard shipping. Express shipping is free on qualifying baskets over CAD 300, while Standard shipping is free on qualifying baskets over CAD 200. Checkout confirms the applicable shipping method, charge, and eligibility. Delivery estimates can vary with destination and transport conditions, particularly for rural, northern, or remote communities.
Approximate Shipping Times to Canadian Cities - Canada
City Express Standard Sherbrooke ≈ 5 days ≈ 18 days St. Johns ≈ 7 days ≈ 20 days Windsor ≈ 5 days ≈ 15 days London (ON) ≈ 7 days ≈ 21 days Kelowna ≈ 7 days ≈ 14 days
Actoplus Met can be a practical fixed-dose option for selected adults with type 2 diabetes who benefit from metformin and pioglitazone together. The decision should account for heart failure risk, fluid retention, kidney and liver monitoring, interactions, and individual treatment goals. Canadians can compare community pharmacy access, provincial or territorial plans, private insurance, and our delivery options while maintaining regular contact with a prescriber and pharmacist.
I have type 2 diabetes and a history of heart failure. Is the pioglitazone in this combination something I need to raise with my doctor before starting?
Yes. Pioglitazone can cause fluid retention and may worsen or trigger heart failure, so a clinician needs to assess whether this combination is appropriate in someone with a history of heart failure. New or worsening shortness of breath, rapid weight gain, or swelling of the ankles or legs needs prompt medical attention.
| Active ingredient | Pioglitazone and metformin |
|---|---|
| Drug class | Antidiabetic combination (thiazolidinedione and biguanide) |
| Dosage form | Tablet |
| Available strengths | 15 mg/500 mg |
| Route | Oral |
| Storage | Store at 25°C; excursions permitted from 15°C to 30°C. Keep the container tightly closed and protect from moisture and humidity. |
| ATC code | A10BD05 |
This product has 17 ratings, but only 1 written review so far. Share your experience and help other customers.
Good value overall.